Get started
Author

Brian Werneburg

Clinical and real-world pharmacovigilance data of meningococcal infections in eculizumab- or ravulizumab-treated patients
2023 · Sami Fam, Brian Werneburg, et al. · Journal of the Neurological Sciences · 5
PDF
Change in Concomitant Therapies for Generalized Myasthenia Gravis in Patients Receiving Eculizumab: a Retrospective Analysis of Registry Data (P1-5.002)
2023 · Michael Pulley, Samir Macwan, et al. · Neurology · 5
Change in concomitant therapies for generalized myasthenia gravis in patients receiving eculizumab: A retrospective analysis of registry data
2023 · Michael Pulley, Samir Macwan, et al. · Journal of the Neurological Sciences · 2
PDF
Zorevunersen Demonstrates Potential as a Disease-modifying Therapy in Patients with Dravet Syndrome Through Durable Seizure Reduction and Improvements in Cognition, Behavior, and Quality of Life Through 36 Months of Treatment in Open-label Extension Studies (S19.007)
2026 · Linda Laux, Kelly G. Knupp, et al. · Neurology
Identifying digital biomarkers for the self-monitoring of patients living with generalized myasthenia gravis: A proof of concept
2023 · Pascal Laforêt, David Orlikowski, et al. · Journal of the Neurological Sciences
Assessing the extent of symptom control provided by ravulizumab or efgartigimod in generalised myasthenia gravis
2023 · Adrian Kielhorn, Brian Werneburg, et al. · Journal of the Neurological Sciences
Identifying Digital Biomarkers for the Self-Monitoring of Patients Living with Generalized Myasthenia gravis: a Proof of Concept (P7-8.007)
2023 · Pascal Laforet, David Orlikowski, et al. · Neurology
Works count: 7
Citation count: 12
H-index: 2
I10-index:
Year
Topic
Type